Northwest Biotherapeutics NWBO Estimates

OTC NWBO
$0.15 -0.01 (-6.25%)
At close: Sep 28, 2026 · 4:00 PM EDT
Analyst Estimates

Northwest Biotherapeutics Inc Annual Revenue Estimates

Periods 5
Next Period 2017
Consensus 652.16 M

Analysts expect Northwest Biotherapeutics Inc to report revenue of 652.16 M for 2017, against a range of 605.46 M to 698.86 M. The most recent reported year, 2025, came in at 0.00.

Metric 20172018202520262027
Reported (Actual) --0.00
High Estimate 698.86 M1.41 B-
Low Estimate 605.46 M1.23 B-
Consensus Estimate 652.16 M1.32 B-
Analyst Estimates

Northwest Biotherapeutics Inc Annual Earnings Per Share (EPS) Estimates

Periods 5
Next Period 2017
Consensus 3.70

Analysts expect Northwest Biotherapeutics Inc to report earnings per share of 3.70 for 2017, against a range of 3.39 to 4.01. The most recent reported year, 2025, came in at -0.04.

Metric 20172018202520262027
Reported (Actual) ---0.04
High Estimate 4.018.91-
Low Estimate 3.398.33-
Consensus Estimate 3.708.62-

Northwest Biotherapeutics Inc Estimates API

Pull Wall Street consensus for Northwest Biotherapeutics Inc (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/estimates?ticker=NWBO&mode=revenue&api_key=YOUR_API_KEY